Home›Stock Screener›Hikal›Fair Value

Hikal Fair Value

Average Fair Value
₹459.36
Current Market Price: ₹222.06
+106.86% Price Difference

Hikal fair value. Hikal (HIKAL) average fair value is ₹459.36 across 5 valuation models — P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹222.06 (+106.86%), fair value range ₹1.48–₹1350.08.

Fair Value Analysis Export

HIKAL Fair Value vs Current Price — Valuation Summary

HIKAL average fair value, fair value range, price gap and valuation status across 5 models: P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Analyse HIKAL shareholding pattern to track promoter, FII and institutional holdings.

Average Fair Value
₹459.36
Current Market Price
₹222.06
Price Difference
₹237.3
Percentage Difference
+106.86%
Fair Value Range
₹1.48 - ₹1350.08
Methods Used
5
Analysis based on 5 valuation methods: P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF)

P/B Based Valuation

Book Value/Share ₹479.6
Sector Avg P/B 4.13
Historical Avg P/B N/A
Average Fair Value
₹1350.08

Dividend Discount Model

Current Dividend ₹0.6
Growth Rate -21.75%
Required Return 10.0%
Fair Value
₹1.48

Price-to-Sales Valuation

Revenue/Share ₹35.05
Sector Avg P/S 4.0
Fair Value
₹140.21

Asset-Based Valuation

Book Value/Share ₹479.6
Liquidation Value/Share ₹662.2
Fair Value
₹479.6

Discounted Cash Flow (DCF)

Current FCF ₹302.0 Cr
FCF Growth Rate 0.67%
Discount Rate 10.0%
Terminal Growth 3.0%
Enterprise Value ₹4020.03 Cr
DCF Fair Value
₹325.43

HIKAL Fair Value Analysis — Data Sources & Coverage

Hikal financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Hikal stock price NSE.

Methods Used
5
Data Year
2026
Sector
Healthcare

Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.

Data Currency: Financial data is from the current year (2026).

HIKAL vs Healthcare Sector Peers — P/E, P/B & Market Cap

Hikal P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Emcure Pharmaceuticals EMCURE 40.6 8.3 ₹44,381
Modern Diagnostic & Rese… MDRC - 1.42 ₹83
Pharmaids Pharmaceuticals PHARMAID -28.7 2.2 ₹100
Glen Industries GLEN 15.7 1.97 ₹250
Broach Lifecare Hospital BROACH 90.7 0.82 ₹8

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.